Insight into the roles of hepatoma derived growth factor related protein-3 under physiological and pathological conditions

被引:1
|
作者
Eltahir, Heba M. [1 ]
机构
[1] Taibah Univ, Coll Pharm, Dept Pharmacol & Toxicol, Medina, Saudi Arabia
关键词
HRP-3; HDGF; neurons; neurotrophic factor; angiogenic; antiapoptotic; HDGF-RELATED PROTEIN-3; CELL-GROWTH; NEURITE OUTGROWTH; HEPARIN-BINDING; RAPAMYCIN MTOR; FACTOR FAMILY; GENE FAMILY; SPINAL-CORD; EXPRESSION; LOCALIZATION;
D O I
10.1139/bcb-2018-0098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatoma derived growth factor related protein-3 (HRP-3) is a HDGF growth factor family member that is expressed mainly in nervous tissues. It shares structural similarities with HDGF but differs in its expression and scope of action. It has recently attracted more attention due to its variable roles. HRP-3 was originally reported as a mitogenic factor. However, over the last decade, additional functions for this growth factor have been uncovered. In addition to its mitogenic activity, other physiological functions were discovered including those related to proliferation, differentiation, and maintenance of neurons, presenting it as a neurotrophic and neuroprotective growth factor. Interestingly, HRP-3 was also shown to be involved in the pathogenesis of certain tumors via its mitogenic, angiogenic, and antiapoptotic effects. Based on this, HRP-3 represents a molecule that can be targeted for the treatment of cancer and various neurodegenerative diseases.
引用
收藏
页码:707 / 712
页数:6
相关论文
共 50 条
  • [41] Expression of insulin-like growth factor binding protein-3 in HELLP syndrome
    Wei, Li
    Liping, Zhou
    Suya, Kang
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [42] Sera from patients with age-related cataract have antibody to a hepatoma derived growth factor-like protein.
    Singh, DP
    Kikuchi, T
    Sueno, T
    Reddy, VN
    Chylack, LT
    Shinohara, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 212 - 212
  • [43] Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2
    Shetty, Aditya
    Dasari, Subramanyam
    Banerjee, Souresh
    Gheewala, Taher
    Zheng, Guoxing
    Chen, Aoshuang
    Kajdacsy-Balla, Andre
    Bosland, Maarten C.
    Munirathinam, Gnanasekar
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 483.e1 - 483.e8
  • [44] A new mutation in the bovine insulin-like growth factor binding protein-3
    Haegeman, A
    Van Zeveren, A
    Peelman, LJ
    ANIMAL GENETICS, 1999, 30 (05) : 395 - 396
  • [45] Insulin-like growth factor binding protein-3 in patients with liver cirrhosis
    Sídlová, K
    Pechová, M
    Kotaska, K
    Prusa, R
    PHYSIOLOGICAL RESEARCH, 2002, 51 (06) : 587 - 590
  • [46] Expression of insulin-like growth factor binding protein-3 in pterygium tissue
    Wong, Y. W.
    Chew, J.
    Yang, H.
    Tan, D. T. H.
    Beuerman, R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (06) : 769 - 772
  • [47] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 - BIOCHEMISTRY AND PHYSIOLOGY
    MARTIN, JL
    BAXTER, RC
    GROWTH REGULATION, 1992, 2 (02): : 88 - 99
  • [48] GLUCOCORTICOID REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3
    VILLAFUERTE, BC
    KOOP, BL
    PAO, CI
    PHILLIPS, LS
    ENDOCRINOLOGY, 1995, 136 (05) : 1928 - 1933
  • [49] No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis
    Skjærbæk, C
    Kaal, A
    Moller, J
    Vahl, N
    Weeke, J
    Orskov, H
    Flyvbjerg, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1206 - 1210
  • [50] Bone morphogenetic protein-3 is a negative regulator of transforming growth factor beta and fibrosis
    Dorris, Emma R.
    Phelan, David E.
    Russell, John
    Murphy, Madeline
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 738